NovoCure's Interest & Investment Income fell 4290.47% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.2 million, marking a year-over-year decrease of 4686.36%. This contributed to the annual value of $39.3 million for FY2024, which is 1455.82% down from last year.
Per NovoCure's latest filing, its Interest & Investment Income stood at $6.0 million for Q3 2025, which was down 4290.47% from $4.5 million recorded in Q2 2025.
In the past 5 years, NovoCure's Interest & Investment Income ranged from a high of $18.5 million in Q4 2022 and a low of -$2.2 million during Q4 2021
Moreover, its 5-year median value for Interest & Investment Income was $8.8 million (2023), whereas its average is $7.9 million.
As far as peak fluctuations go, NovoCure's Interest & Investment Income skyrocketed by 95209.2% in 2022, and later tumbled by 5814.21% in 2025.
Over the past 5 years, NovoCure's Interest & Investment Income (Quarter) stood at -$2.2 million in 2021, then surged by 952.09% to $18.5 million in 2022, then decreased by 2.4% to $18.1 million in 2023, then crashed by 55.23% to $8.1 million in 2024, then fell by 25.92% to $6.0 million in 2025.
Its last three reported values are $6.0 million in Q3 2025, $4.5 million for Q2 2025, and $7.6 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value